Fujii et al. previously investigated new biomarkers for HCC by proteomics analysis, and showed that the expression level of end-binding 1 (EB1), an adenomatous polyposis coli (APC)-binding protein, was higher in hepatoma cell lines compared with normal hepatocyte cell lines [4]. This evidence concerns the gene MAPRE1 and hepatocellular carcinoma.